Literature DB >> 18370114

Detection of protein-protein interactions in live cells and animals with split firefly luciferase protein fragment complementation.

Victor Villalobos1, Snehal Naik, David Piwnica-Worms.   

Abstract

Protein fragment complementation has emerged as a powerful tool for measuring protein-protein interactions in the context of live cells. The adaptation of this strategy for use with firefly luciferase now allows for the non-invasive, quantitative, real-time readout of protein interactions in lysates, live cells, and whole animals. Bioluminescence provides a robust imaging modality due to its extremely low background signal and large dynamic range. The split luciferase fusion constructs described here are inducible by addition of ligands, small molecules or drugs, in this example, rapamycin, and have been shown to work in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370114     DOI: 10.1007/978-1-59745-188-8_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Targeting the dimerization of epidermal growth factor receptors with small-molecule inhibitors.

Authors:  Robert Y C Yang; Katherine S Yang; Linda J Pike; Garland R Marshall
Journal:  Chem Biol Drug Des       Date:  2010-05-04       Impact factor: 2.817

Review 2.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Wei-Chun J Hsu; Norelle C Wildburger; Sigmund J Haidacher; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya K Singh; Brent C Chesson; Whitney F Franklin; Ibdanelo Cortez; Rovshan G Sadygov; Kelly T Dineley; Jay S Rudra; Giulio Taglialatela; Cheryl F Lichti; Larry Denner; Fernanda Laezza
Journal:  Exp Neurol       Date:  2017-05-15       Impact factor: 5.330

4.  Dynamic analysis of GH receptor conformational changes by split luciferase complementation.

Authors:  Ying Liu; Philip A Berry; Yue Zhang; Jing Jiang; Peter E Lobie; Ramasamy Paulmurugan; John F Langenheim; Wen Y Chen; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-04

5.  Protein-Protein Interactions as New Targets for Ion Channel Drug Discovery.

Authors:  Svetla Stoilova-McPhie; Syed Ali; Fernanda Laezza
Journal:  Austin J Pharmacol Ther       Date:  2013-12-31

6.  Expanding the utility of beta-galactosidase complementation: piece by piece.

Authors:  Ann-Marie Broome; Nihir Bhavsar; Gopalakrishnan Ramamurthy; Gail Newton; James P Basilion
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

7.  Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Authors:  Yujun Gan; Ashiya Buckels; Ying Liu; Yue Zhang; Andrew J Paterson; Jing Jiang; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-11

8.  Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor.

Authors:  Ying Liu; Jing Jiang; Bradford Lepik; Yue Zhang; Kurt R Zinn; Stuart J Frank
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

9.  GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.

Authors:  Ying Liu; Yue Zhang; Jing Jiang; Peter E Lobie; Ramasamy Paulmurugan; John F Langenheim; Wen Y Chen; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2016-03-22

10.  Formation and toxicity of soluble polyglutamine oligomers in living cells.

Authors:  Patrick Lajoie; Erik Lee Snapp
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.